Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Sanofi (SNY) Restructuring Costs (2016)

Historic Restructuring Costs for Sanofi (SNY) over the last 8 years, with Q1 2016 value amounting to -$551.5 million.

  • Sanofi's Restructuring Costs fell 3828.07% to -$551.5 million in Q1 2016 from the same period last year, while for Mar 2016 it was -$1.5 billion, marking a year-over-year decrease of 16536.78%. This contributed to the annual value of $1.3 billion for FY2025, which is 1488.39% down from last year.
  • As of Q1 2016, Sanofi's Restructuring Costs stood at -$551.5 million, which was down 3828.07% from -$871.4 million recorded in Q4 2015.
  • Over the past 5 years, Sanofi's Restructuring Costs peaked at $1.5 billion during Q4 2012, and registered a low of -$871.4 million during Q4 2015.
  • Moreover, its 5-year median value for Restructuring Costs was $69.9 million (2014), whereas its average is -$28.5 million.
  • As far as peak fluctuations go, Sanofi's Restructuring Costs surged by 17198.69% in 2012, and later crashed by 67066.62% in 2015.
  • Sanofi's Restructuring Costs (Quarter) stood at $1.5 billion in 2012, then plummeted by 127.87% to -$412.4 million in 2013, then fell by 22.43% to -$504.9 million in 2014, then tumbled by 72.58% to -$871.4 million in 2015, then skyrocketed by 36.71% to -$551.5 million in 2016.
  • Its Restructuring Costs stands at -$551.5 million for Q1 2016, versus -$871.4 million for Q4 2015 and -$64.5 million for Q3 2015.